2% population develops autoantibodies against type 1 interferons, increasing susceptibility to viral diseases like COVID-19, study by University of Zurich and University Hospital Zurich reveals.

2% of the population develop autoantibodies against type 1 interferons, increasing susceptibility to viral diseases like COVID-19, as found by researchers from the University of Zurich and University Hospital Zurich. These autoantibodies, which affect the immune system, typically appear between ages 60 to 65 and can persist for a person's lifetime.

July 17, 2024
5 Articles